Work

Effect of age and lenvatinib treatment on overall survival for patients with 131I-refractory differentiated thyroid cancer in SELECT.

Year: 2015

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2015.33.15_suppl.6048

Authors: Marcia S. Brose, Martin Schlumberger, Makoto Tahara, Lori J. Wirth, Bruce Robinson, Rossella Elisei, Kate Newbold, Naomi Kiyota, Ana O. Hoff, Corina Dutcus, James Song, Steven I. Sherman, Matthew Hiram Taylor

Institutions: Abramson Cancer Center, University of Pennsylvania, Institut Gustave Roussy, National Cancer Center Hospital East, Massachusetts General Hospital, The University of Sydney, University of Pisa, National Health Service, Royal Marsden NHS Foundation Trust, Royal Marsden Hospital, Kobe University Hospital, Universidade de São Paulo, Instituto do Câncer do Estado de São Paulo, Eisai (United States), The University of Texas MD Anderson Cancer Center, OHSU Knight Cancer Institute

Language: English

Topic: Thyroid Cancer Diagnosis and Treatment

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2440396977

Cites:

Cited by: 12

Related to: 10